Would you offer focal prostate boost per FLAME protocol for GTV defined by PET alone without MRI?
PSMA or Flucyclovine defined focal nodule
Answer from: Radiation Oncologist at Academic Institution
I think there are two questions here:
Can you use PSMA PET to define the boost target? Yes (with a little bit of caution). There have been several reports on the safety/feasibility of PSMA-based focal boost. Note, though, that FLAME was based on MRI, and we can expect that the PET-defined lesion ma...
Comments
Radiation Oncologist at Lafayette Radiation Center Yes
Radiation Oncologist at Texas Oncology A follow-up question I had is whether you consider...
Radiation Oncologist at UC San Diego Yes. I prefer 28 fractions to be a little closer t...
Radiation Oncologist at Orlando Health UF Health Cancer Center Health Central Hospital Another Question. For high risk patients; they sti...
Radiation Oncologist at UC San Diego Great question. Given that we know (a) ADT changes...
Radiation Oncologist at St. Joseph Cancer Center Question: What are your OAR constraints for the ur...
Radiation Oncologist at UC San Diego FLAME did not have an explicit urethra constraint....
Answer from: Radiation Oncologist at Academic Institution
Great discussion. If people are looking for further discussion, we recently reviewed this topic with the FLAME study team for PRO (Patel et al., PMID 39019208). Specifically, section II.C provides a brief comparison of PET/CT vs. MRI with a discussion of the possible false positives of PET/CT with c...
Answer from: Radiation Oncologist at Community Practice
PSMA PET is actually not that specific within the prostate gland, as shown by Mookerji et al., PMID 38949926 (only 27% specific for tumor laterality compared to prostatectomy specimen). As I learned at the recent World Brachytherapy Congress, "All that lights up may not need to be dose-escalated."&n...
Comments
Radiation Oncologist at Lafayette Radiation Center If you don’t have a good prostate MRI radiol...
Yes
A follow-up question I had is whether you consider...
Yes. I prefer 28 fractions to be a little closer t...
Another Question. For high risk patients; they sti...
Great question. Given that we know (a) ADT changes...
Question: What are your OAR constraints for the ur...
FLAME did not have an explicit urethra constraint....